These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8548840)

  • 1. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis.
    Storkus WJ; Wei M; Cresswell P; Dawson JR
    Cell Immunol; 1996 Jan; 167(1):154-6. PubMed ID: 8548840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing.
    Routes JM
    J Immunol; 1992 Oct; 149(7):2372-7. PubMed ID: 1382100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
    Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
    Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression.
    Shimizu Y; DeMars R
    Eur J Immunol; 1989 Mar; 19(3):447-51. PubMed ID: 2707298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.
    Storkus WJ; Alexander J; Payne JA; Cresswell P; Dawson JR
    J Immunol; 1989 Dec; 143(11):3853-7. PubMed ID: 2479694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-induced modulation of target cell sensitivity to natural killing.
    Storkus WJ; Salter RD; Cresswell P; Dawson JR
    J Immunol; 1992 Aug; 149(4):1185-90. PubMed ID: 1500711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
    Kraus E; Lambracht D; Wonigeit K; Hünig T
    Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.
    Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A
    Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
    Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
    Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
    J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F; Yoshida S
    Oncol Res; 1999; 11(5):213-8. PubMed ID: 10608615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
    Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
    Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.